[1] Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O'Brien SJ, et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 2010;50(6):882 − 9. https://doi.org/10.1086/650733CrossRef
[2] Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 2018;18(3):318 − 27. https://doi.org/10.1016/S1473-3099(17)30753-3CrossRef
[3] Le Hello S, Hendriksen RS, Doublet B, Fisher I, Nielsen EM, Whichard JM, et al. International spread of an epidemic population of Salmonella enterica serotype Kentucky ST198 resistant to ciprofloxacin. J Infect Dis 2011;204(5):675 − 84. https://doi.org/10.1093/infdis/jir409CrossRef
[4] Le Hello S, Harrois D, Bouchrif B, Sontag L, Elhani D, Guibert V, et al. Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. Lancet Infect Dis 2013;13(8):672 − 9. https://doi.org/10.1016/S1473-3099(13)70124-5CrossRef
[5] Le Hello S, Bekhit A, Granier SA, Barua H, Beutlich J, Zając M, et al. The global establishment of a highly-fluoroquinolone resistant Salmonella enterica serotype Kentucky ST198 strain. Front Microbiol 2013;4:395. https://doi.org/10.3389/fmicb.2013.00395CrossRef
[6] Hawkey J, Le Hello S, Doublet B, Granier SA, Hendriksen RS, Fricke WF, et al. Global phylogenomics of multidrug-resistant Salmonella enterica serotype Kentucky ST198. Microb Genom 2019;5(7):e000269. https://doi.org/10.1099/mgen.0.000269CrossRef
[7] Chen HH, Song JJ, Zeng XY, Chen DD, Chen RC, Qiu C, et al. National prevalence of Salmonella enterica serotype Kentucky ST198 with high-level resistance to ciprofloxacin and extended-spectrum cephalosporins in China, 2013 to 2017. mSystems 2021;6(1):e00935 − 20. https://doi.org/10.1128/mSystems.00935-20CrossRef
[8] Xiong ZY, Wang SJ, Huang YM, Gao Y, Shen HY, Chen ZQ, et al. Ciprofloxacin-resistant Salmonella enterica serovar Kentucky ST198 in broiler chicken supply chain and patients, China, 2010-2016. Microorganisms 2020;8(1):140. https://doi.org/10.3390/microorganisms8010140CrossRef
[9] Wang J, Jiang Y, Ji RY, Wang ZY, Lu MJ, Wu H, et al. Colistin- and tigecycline-resistant CTX-M-14-producing Salmonella enterica serovar Kentucky ST198 from retail chicken meat, China. Int J Antimicrob Agents 2022;59(2):106504. https://doi.org/10.1016/j.ijantimicag.2021.106504CrossRef
[10] She YY, Jiang YX, Luo MM, Duan XK, Xie L, Yang C, et al. Emergence of chromosomally located blaCTX-M-14b and qnrS1 in Salmonella enterica serotype Kentucky ST198 in China. Int J Antimicrob Agents 2023;62(3):106896. https://doi.org/10.1016/j.ijantimicag.2023.106896CrossRef
[11] Ho PL, Lo WU, Yeung MK, Li Z, Chan J, Chow KH, et al. Dissemination of pHK01-like incompatibility group IncFII plasmids encoding CTX-M-14 in Escherichia coli from human and animal sources. Vet Microbiol 2012;158(1-2):172 − 9. https://doi.org/10.1016/j.vetmic.2012.02.004CrossRef
[12] Xu HY, Cao XL, Zhang WB, Li QC. Co-existence of two ciprofloxacin-resistant Salmonella enterica serovar Kentucky strains in the urine of a bladder cancer patient. J Glob Antimicrob Resist 2022;30:354 − 6. https://doi.org/10.1016/j.jgar.2022.07.011CrossRef
[13] Haley BJ, Kim SW, Haendiges J, Keller E, Torpey D, Kim A, et al. Salmonella enterica serovar Kentucky recovered from human clinical cases in Maryland, USA (2011-2015). Zoonoses Public Health 2019;66(4):382 − 92. https://doi.org/10.1111/zph.12571CrossRef